Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03032640 · ClinicalTrials.gov registry record · NA
Interactions of Human Gut Microbiota With Intestinal Sweet Taste Receptors
A NA study, sponsored by AdventHealth Translational Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 102
- Enrollment target
NCT03032640: Completed NA study, sponsored by AdventHealth Translational Research Institute.
NCT03032640 is a NA study that has completed, run by AdventHealth Translational Research Institute. The registered enrollment target is 102 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03032640, a NA study, has completed, sponsored by AdventHealth Translational Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
Study Summary
The purpose of this study is to collect data to examine whether short-term consumption of non-caloric artificial sweeteners (NCASs), such as saccharin, can lead to changes in blood sugar levels and in the composition of the bacteria in the large intestine.
Interventions
- OTHER Placebo
- OTHER Oral Glucose Tolerance Test (OGTT)
- OTHER Assessment of dietary compliance
- OTHER Stool sampling
- OTHER Sodium Saccharin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2017-01-26 |
| Est. Completion | 2022-10-18 |
| Phase | NA |
What the finished NCT03032640 record still lists
NCT03032640 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT03032640 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03032640 about?
NCT03032640 is a clinical study titled "Interactions of Human Gut Microbiota With Intestinal Sweet Taste Receptors". The purpose of this study is to collect data to examine whether short-term consumption of non-caloric artificial sweeteners (NCASs), such as saccharin, can lead to changes in blood sugar levels and in the composition of the bacteria in the large intestine.
What is the current status of trial NCT03032640?
This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2017-01-26. Estimated completion is 2022-10-18.
What interventions are being tested in trial NCT03032640?
The interventions under investigation include: Placebo (OTHER), Oral Glucose Tolerance Test (OGTT) (OTHER), Assessment of dietary compliance (OTHER), Stool sampling (OTHER), Sodium Saccharin (OTHER).
Who is sponsoring clinical trial NCT03032640?
This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03032640's enrollment target sits among peer trials
102 837th of 2000 higher than 1,161 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI